Vericel (VCEL) Gross Margin (2011 - 2026)
Vericel recorded quarterly Gross Margin of 72.0% in Q1 2026, down 8.52% quarter-over-quarter from 78.7% in Q4 2025, and up 304.0% year-over-year from 17.82% in Q1 2025.
Vericel's Gross Margin history runs 16 years deep, the most recent figure standing at 72.0% for Q1 2026.
- In Q1 2026, Gross Margin rose 304.0% year-over-year to 72.0%; the TTM figure through Mar 2026 stood at 74.84% (up 230.0% YoY), while the FY2025 annual figure was 74.42%, up 187.0% from the prior year.
- Gross Margin came in at 72.0% for Q1 2026 at Vericel, down from 78.7% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 78.7% in Q4 2025 to a low of 61.69% in Q2 2022.
- A 5-year average of 70.09% and a median of 69.5% in 2024 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin plunged 640 bps in 2022 and jumped 478 bps in 2024, its largest moves.
- Vericel's Gross Margin stood at 72.59% in 2022, then gained by 3 bps to 74.63% in 2023, then gained by 4 bps to 77.61% in 2024, then climbed by 1 bps to 78.7% in 2025, then retreated by 9 bps to 72.0% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 72.0%, 78.7%, and 73.46% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 82.22% |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | 72.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.00% |
| Dec 31, 2025 | 78.70% |
| Sep 30, 2025 | 73.46% |
| Jun 30, 2025 | 73.71% |
| Mar 31, 2025 | 68.96% |
| Dec 31, 2024 | 77.61% |
| Sep 30, 2024 | 71.93% |
| Jun 30, 2024 | 69.50% |
| Mar 31, 2024 | 68.94% |
| Dec 31, 2023 | 74.63% |
| Sep 30, 2023 | 67.15% |
| Jun 30, 2023 | 65.20% |
| Mar 31, 2023 | 64.66% |
| Dec 31, 2022 | 72.59% |
| Sep 30, 2022 | 65.45% |
| Jun 30, 2022 | 61.69% |
| Mar 31, 2022 | 65.41% |
| Dec 31, 2021 | 71.51% |
| Sep 30, 2021 | 64.04% |
| Jun 30, 2021 | 68.09% |
| Mar 31, 2021 | 68.35% |
| Dec 31, 2020 | 74.39% |
| Sep 30, 2020 | 69.66% |
| Jun 30, 2020 | 56.73% |
| Mar 31, 2020 | 62.81% |
| Dec 31, 2019 | 73.13% |
| Sep 30, 2019 | 69.43% |
| Jun 30, 2019 | 65.50% |
| Mar 31, 2019 | 60.39% |
| Dec 31, 2018 | 72.46% |
| Sep 30, 2018 | 63.81% |
| Jun 30, 2018 | 59.36% |
| Mar 31, 2018 | 57.47% |
| Dec 31, 2017 | 64.07% |
| Sep 30, 2017 | 49.61% |
| Jun 30, 2017 | 54.76% |
| Mar 31, 2017 | 24.06% |
| Dec 31, 2016 | 64.07% |
| Sep 30, 2016 | 37.27% |
| Jun 30, 2016 | 43.07% |
| Mar 31, 2016 | 53.50% |
| Dec 31, 2015 | 53.12% |
| Sep 30, 2015 | 40.12% |
| Jun 30, 2015 | 49.22% |
| Mar 31, 2015 | 48.68% |
| Dec 31, 2014 | 54.09% |
| Sep 30, 2014 | 42.72% |
| Jun 30, 2014 | -13.02% |
| Dec 31, 2013 | 87.50% |
| Jun 30, 2013 | 66.67% |
| Mar 31, 2013 | 75.00% |
| Dec 31, 2012 | 78.95% |
| Sep 30, 2011 | 77.78% |
| Mar 31, 2011 | 77.78% |